← Eichor
Condition: Cbd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cbd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Modulation of THC Effects by CBD: a Dose-ranging Study
Phase 1/Phase 2 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT06099379MIVetsCan: Can-Coach Trial (Phase 2)
NA · 1 location(s) · University of Michigan · NCT06283862Optimal Timings of Laparoscopic Cholecystectomy After ERCP in Patients With Gallstones Along With CBD Stones
NA · 1 location(s) · Rija Zainab · NCT07517627Cannabis Use, Cognition, and the Endocannabinoid System in HIV
EARLY_Phase 1 · 1 location(s) · University of California, San Diego · NCT04883255CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06840899Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
EARLY_Phase 1 · 1 location(s) · Washington State University · NCT06692933Laser vs Electrohydraulic Lithotripsy for Difficult CBD Stones
NA · 2 location(s) · Mahidol University · NCT07030829Cannabidiol Into Breastmilk
NA · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT06589258Imaging Studies in Corticobasal Syndrome
Phase N/A · 1 location(s) · Jennifer Whitwell · NCT07000851MIVetsCan: Cannabidiol (CBD)-Care Trial
Phase 2 · 1 location(s) · Kevin Boehnke · NCT06213233Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Phase 1/Phase 2 · 1 location(s) · Staci Gruber, Ph.D. · NCT07728695Efficacy and Safety of Surgical Treatment for Type IVa CBD
Phase N/A · 1 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT07036848Effects of Cannabidiol on Stress and Nicotine Withdrawal
Phase 1 · 1 location(s) · Johns Hopkins University · NCT07001930Cannabidiol for Bipolar Depression (CBD-BD)
Phase 3 · 6 location(s) · University of British Columbia · NCT05867849Cannabidiol (CBD) in Adults With ASD
Phase 1 · 1 location(s) · Johns Hopkins University · NCT05015439Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms
NA · 1 location(s) · University of Minnesota · NCT07069478ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Phase N/A · 27 location(s) · Mayo Clinic · NCT04363684Alcohol Use Disorder and Cannabidiol
Phase 2/Phase 3 · 1 location(s) · University of Colorado, Denver · NCT05613608Cannabidiol Effects on Learning and Anxiety
EARLY_Phase 1 · 1 location(s) · University of Connecticut · NCT05283382Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach
Phase 3 · 1 location(s) · UMC Utrecht · NCT07668856The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
Phase 2 · 1 location(s) · Bazelet Nehushtan LtD. · NCT06542445Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults
Phase 2 · 1 location(s) · University of Nebraska · NCT05269459Study of Cannabidiol in Sanfilippo Syndrome
Phase 2/Phase 3 · 1 location(s) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA · NCT06333041Cannabidiol Medication Intervention Trial
Phase 2 · 5 location(s) · Sunnybrook Health Sciences Centre · NCT06014424Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
Phase 2 · 1 location(s) · Eastern Virginia Medical School · NCT04436081Longitudinal Outpatient Treatment for Cannabis Use Disorder
Phase 2 · 1 location(s) · University of Colorado, Boulder · NCT06107062The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regi
Phase 1 · 2 location(s) · University of California, San Diego · NCT06393101Cannabidiol for Reduction of Brain Neuroinflammation
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05066308CBD for Breast Cancer Primary Tumors
Phase 1 · 1 location(s) · Medical University of South Carolina · NCT06148038CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05410717
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.